IAIM
ALNY icon

Industrial Alliance Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Industrial Alliance Investment Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,900
Closed -$1.38M – 434
2022
Q3 		$1.38M Sell
6,900
-9,870
-59% -$1.88M 0.04% 242
2022
Q2 		$2.45M Buy
+16,770
New +$2.38M 0.07% 206

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Industrial Alliance Investment Management's ALNY Position: Q4 2022 in Review

Industrial Alliance Investment Management sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2022, closing a stake of 6,900 shares — an estimated $1.38M sold.

Industrial Alliance Investment Management first reported a position in ALNY in Q2 2022 and held it in 2 quarters. The position peaked at $2.45M in Q2 2022. 488 funds tracked by Wall St. Rank hold ALNY as of Q4 2022.

  • Industrial Alliance Investment Management reported no remaining Alnylam Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Industrial Alliance Investment Management sold 6,900 Alnylam Pharmaceuticals shares in Q4 2022, an estimated $1.38M.
  • Industrial Alliance Investment Management first reported a position in Alnylam Pharmaceuticals in Q2 2022 and held it in 2 quarters.
  • Industrial Alliance Investment Management's Alnylam Pharmaceuticals position peaked at $2.45M in Q2 2022.
  • 488 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2022.

Based on Industrial Alliance Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.